Changzhou Weipu Medical Devices Co., Ltd.
Changzhou Weipu Medical Devices Co., Ltd. is located in Xinbei District Changzhou City, in the Golden Triangle of the Yangtze River, here we have superior geographical location and convenient transportation.The company covers an area of over 20000 square meters and is dedicated to the research and development, production, sales, and service of medical devices.
As one of the largest OEM manufacturer in China, we achieve full inspection of each product and specification, with a large workload every time. We have a strong commitment to healthcare professionals, and we are proving it every day. Although it is time-consuming and labor-intensive, and increases costs, the quality reputation of Weipu brand has won recognition from the market and customers.
Our company adheres to the corporate philosophy of "customer first, technological innovation, reliable quality", and has a large number of professional talents, laying a solid foundation for the company to continuously surpass and pursue better goals. The company actively follows the ISO13485 quality management system, strictly manages quality, ensures product quality, provides trustworthy products for users, and receives recognition from the majority of users with the most thoughtful service.
Healthcare professionals inspire our wound management, prevention and surgical solutions. Their relentless search for new and better ways to care for patients drives us to innovate. And the research and development of new products is the source of maintaining a company's market advantage and competitiveness. Therefore, we always insist on paying tribute to life with innovation, patient safety first and clinical effect first.
Changzhou Weipu Medical Devices Co., Ltd.
Changzhou Weipu Medical Devices Co., Ltd. is located in Xinbei District Changzhou City, in the Golden Triangle of the Yangtze River, here we have superior geographical location and convenient transportation.The company covers an area of over 20000 square meters and is dedicated to the research and development, production, sales, and service of medical devices.
As one of the largest OEM manufacturer in China, we achieve full inspection of each product and specification, with a large workload every time. We have a strong commitment to healthcare professionals, and we are proving it every day. Although it is time-consuming and labor-intensive, and increases costs, the quality reputation of Weipu brand has won recognition from the market and customers.
Our company adheres to the corporate philosophy of "customer first, technological innovation, reliable quality", and has a large number of professional talents, laying a solid foundation for the company to continuously surpass and pursue better goals. The company actively follows the ISO13485 quality management system, strictly manages quality, ensures product quality, provides trustworthy products for users, and receives recognition from the majority of users with the most thoughtful service.
Healthcare professionals inspire our wound management, prevention and surgical solutions. Their relentless search for new and better ways to care for patients drives us to innovate. And the research and development of new products is the source of maintaining a company's market advantage and competitiveness. Therefore, we always insist on paying tribute to life with innovation, patient safety first and clinical effect first.
Alcon (China) Ophthalmic Products Co., Ltd.
Alcon is a global leader in the field of ophthalmic health care, focusing on helping people see a brighter world. With a history of more than 75 years, Alcon is one of the world's largest ophthalmic nursing equipment companies, with complementary business advantages in surgical products and vision care. In 1945, two pharmacists, Robert Alexander and William Conner, opened a small pharmacy in Fort Worth, Texas, and combined the syllables of their last name into the pharmacy name "Alcon". Alcon has achieved its position in the ophthalmology field through innovative and breakthrough technologies, and has improved the way people treat eye diseases and improve vision. Alcon has a wealth of ophthalmic products in the industry, divided into two major business areas: ophthalmic surgery and vision care. Alcon provides a wide range of ophthalmic surgical products that can cover the entire life cycle of ophthalmic diseases, helping doctors achieve better treatment results. The product portfolio includes advanced technology intraocular lenses, comprehensive refractive cataract platform, digital vitreous retinal surgery platform and visual quality refractive integrated platform. Alcon's high-quality contact lenses and care liquid products can meet the needs of all kinds of consumers. Contact lens products include transparent daily throwing, color daily throwing and monthly throwing contact lenses. Contact lens care liquid and eye moisturizing products can bring consumers a lasting and comfortable wearing experience. In addition, the Alcon family of artificial tears products can help alleviate the increasingly severe symptoms of dry eyes.
Alcon (China) Ophthalmic Products Co., Ltd.
Alcon is a global leader in the field of ophthalmic health care, focusing on helping people see a brighter world. With a history of more than 75 years, Alcon is one of the world's largest ophthalmic nursing equipment companies, with complementary business advantages in surgical products and vision care. In 1945, two pharmacists, Robert Alexander and William Conner, opened a small pharmacy in Fort Worth, Texas, and combined the syllables of their last name into the pharmacy name "Alcon". Alcon has achieved its position in the ophthalmology field through innovative and breakthrough technologies, and has improved the way people treat eye diseases and improve vision. Alcon has a wealth of ophthalmic products in the industry, divided into two major business areas: ophthalmic surgery and vision care. Alcon provides a wide range of ophthalmic surgical products that can cover the entire life cycle of ophthalmic diseases, helping doctors achieve better treatment results. The product portfolio includes advanced technology intraocular lenses, comprehensive refractive cataract platform, digital vitreous retinal surgery platform and visual quality refractive integrated platform. Alcon's high-quality contact lenses and care liquid products can meet the needs of all kinds of consumers. Contact lens products include transparent daily throwing, color daily throwing and monthly throwing contact lenses. Contact lens care liquid and eye moisturizing products can bring consumers a lasting and comfortable wearing experience. In addition, the Alcon family of artificial tears products can help alleviate the increasingly severe symptoms of dry eyes.
Shenzhen Yibainian Investment Industrial Co., Ltd.
Shenzhen Yi Bonian Investment Sandwich Industry Co., Ltd. is a high-tech innovative enterprise focusing on the research and development, manufacturing, sales, and service of hydrogen health products. Focusing on the core of the big health industry, expanding human health, and serving the world are the goal pursued by the Yi Bonian people. The company has a core and high-quality R&D team, focusing on the development of software and hardware for hydrogen molecular health products. He is proficient in the R&D, design, and production of snow energy equipment products, and is committed to guiding the direction of hydrogen molecular products. With the responsibility of serving public health and the leading role of innovation and technology, we always pursue high-quality products and services. Provide customers with convenient and reliable services online and offline, public health, hydrogen pine realization, hydrogen care, and healthy life, so that hydrogen energy series products can benefit the public for a better life.
Shenzhen Yibainian Investment Industrial Co., Ltd.
Shenzhen Yi Bonian Investment Sandwich Industry Co., Ltd. is a high-tech innovative enterprise focusing on the research and development, manufacturing, sales, and service of hydrogen health products. Focusing on the core of the big health industry, expanding human health, and serving the world are the goal pursued by the Yi Bonian people. The company has a core and high-quality R&D team, focusing on the development of software and hardware for hydrogen molecular health products. He is proficient in the R&D, design, and production of snow energy equipment products, and is committed to guiding the direction of hydrogen molecular products. With the responsibility of serving public health and the leading role of innovation and technology, we always pursue high-quality products and services. Provide customers with convenient and reliable services online and offline, public health, hydrogen pine realization, hydrogen care, and healthy life, so that hydrogen energy series products can benefit the public for a better life.
Xuzhou Kailier Sauna Equipment CO.,LTD
**Company Background and History**
Xuzhou Kailier Sauna Equipment Co., Ltd. was established in 1995, specializing in the research, development and production of far-infrared sauna products, with nearly 30 years of experience in the industry. The company was founded by a well-known local furniture craftsman. With a deep understanding of product structure and appearance design, Kelier has gradually grown into a comprehensive enterprise integrating R&D, production and sales.
Over the years, we have improved our management level and production efficiency through systematization and informationization. Our customers are all over East Asia, Europe and America, and we have successfully penetrated into high standard markets such as Germany and Japan. Currently, our export share is mainly concentrated in Germany (50%), the United States (30%), South Korea (10%), and other markets account for 10%.
**Capacity and Market Adjustment**
Kailier has excellent production capacity, especially in the far-infrared footbath production line, with a monthly capacity of 12,000-15,000 units, mainly supplying the Korean market. Due to the recent economic downturn in the market leading to a decrease in orders, the company has decided to shift part of the production capacity of the footbath bucket production line to the pet product market in order to fill the capacity gap.
**Pet Product Development**
Kailier has systematically built its R&D team since 2013, focusing on new product development and technological innovation. The company has an advanced production management system, introduced MRP II type production management mode as early as 2014, and independently developed production management system to realize high efficiency production, accurate delivery prediction and smooth production flow. The monthly production capacity can reach 1,500-2,000 saunas (about 30 containers), and 12,000-15,000 footbath buckets or pet products. In recent years, the company has also introduced a number of automated and intelligent production equipment, which has significantly improved production efficiency and product quality.
**Department structure and Team**
Kailier has a perfect organizational structure, the coordinated operation of all departments to ensure efficient production and strict quality control of products:
【Foreign Trade Department and Domestic Trade Department】：Responsible for the development and maintenance of international and domestic markets respectively.
【Production Department】：Responsible for production planning and manufacturing process to ensure efficient operation.
[Follow-up Department]: Manage orders and customer communication to ensure accurate order processing and customer satisfaction.
【Quality Department】：Including 7 quality control professionals, responsible for product quality control and testing.
【Engineering Department】：Including 2 electrical engineers, 1 BOM engineer and 3 engineering structural engineers, responsible for product development and technical support.
【Incoming Material Inspection】: Strictly control the quality of raw materials.
【Design Department】: including 1 3D design engineer and 1 graphic designer, responsible for product appearance design and visual image.
【Documentation Department】: 1 single certificate specialist, responsible for the management of export-related documents.
【Capital & Finance Department】: Responsible for the company's financial management and resource planning to ensure financial health and rational allocation of resources to support the company's sustainable development.
**Informatization management and quality control**
The company adopts advanced ERP system for comprehensive management, covering all aspects of purchasing, production, sales, inventory and finance, ensuring real-time sharing of information and efficient operation of management. In terms of quality control, the company is equipped with large-scale experimental and testing equipment, and implements strict multiple inspection methods to ensure that the appearance and reliability of the products meet the high standards of the industry.
Xuzhou Kailier Sauna Equipment CO.,LTD
**Company Background and History**
Xuzhou Kailier Sauna Equipment Co., Ltd. was established in 1995, specializing in the research, development and production of far-infrared sauna products, with nearly 30 years of experience in the industry. The company was founded by a well-known local furniture craftsman. With a deep understanding of product structure and appearance design, Kelier has gradually grown into a comprehensive enterprise integrating R&D, production and sales.
Over the years, we have improved our management level and production efficiency through systematization and informationization. Our customers are all over East Asia, Europe and America, and we have successfully penetrated into high standard markets such as Germany and Japan. Currently, our export share is mainly concentrated in Germany (50%), the United States (30%), South Korea (10%), and other markets account for 10%.
**Capacity and Market Adjustment**
Kailier has excellent production capacity, especially in the far-infrared footbath production line, with a monthly capacity of 12,000-15,000 units, mainly supplying the Korean market. Due to the recent economic downturn in the market leading to a decrease in orders, the company has decided to shift part of the production capacity of the footbath bucket production line to the pet product market in order to fill the capacity gap.
**Pet Product Development**
Kailier has systematically built its R&D team since 2013, focusing on new product development and technological innovation. The company has an advanced production management system, introduced MRP II type production management mode as early as 2014, and independently developed production management system to realize high efficiency production, accurate delivery prediction and smooth production flow. The monthly production capacity can reach 1,500-2,000 saunas (about 30 containers), and 12,000-15,000 footbath buckets or pet products. In recent years, the company has also introduced a number of automated and intelligent production equipment, which has significantly improved production efficiency and product quality.
**Department structure and Team**
Kailier has a perfect organizational structure, the coordinated operation of all departments to ensure efficient production and strict quality control of products:
【Foreign Trade Department and Domestic Trade Department】：Responsible for the development and maintenance of international and domestic markets respectively.
【Production Department】：Responsible for production planning and manufacturing process to ensure efficient operation.
[Follow-up Department]: Manage orders and customer communication to ensure accurate order processing and customer satisfaction.
【Quality Department】：Including 7 quality control professionals, responsible for product quality control and testing.
【Engineering Department】：Including 2 electrical engineers, 1 BOM engineer and 3 engineering structural engineers, responsible for product development and technical support.
【Incoming Material Inspection】: Strictly control the quality of raw materials.
【Design Department】: including 1 3D design engineer and 1 graphic designer, responsible for product appearance design and visual image.
【Documentation Department】: 1 single certificate specialist, responsible for the management of export-related documents.
【Capital & Finance Department】: Responsible for the company's financial management and resource planning to ensure financial health and rational allocation of resources to support the company's sustainable development.
**Informatization management and quality control**
The company adopts advanced ERP system for comprehensive management, covering all aspects of purchasing, production, sales, inventory and finance, ensuring real-time sharing of information and efficient operation of management. In terms of quality control, the company is equipped with large-scale experimental and testing equipment, and implements strict multiple inspection methods to ensure that the appearance and reliability of the products meet the high standards of the industry.
Stryker (Beijing) Medical Devices Co., Ltd.
As one of the world's cutting-edge medical technology companies, Stryker works sincerely with customers and is committed to improving healthcare. The company provides a range of innovative products and services including plastic surgery, medical and surgical equipment, neurosurgery and spine-related products to help improve the treatment experience of patients and medical institutions. Dr. Homer Stryker, an orthopedic physician in Kalamazoo, Michigan, invented a series of new products after discovering that some medical products cannot meet the needs of patients. There is growing concern and interest in these new medical products, and Dr. Stryker founded The Orthopaedic Frame Company in 1941, specializing in the production of these innovative medical products. In 1942, the company began to build wedge-shaped turnover beds, which allow caregivers to turn over patients with severe back injuries while keeping their spine fixed; In 1946, Stryker founded The Orthopaedic Frame Company; In 1979, the company issued its shares for the first time, bringing more attention to the company; in the same year, Stryker acquired Osteonics Corp. and entered the orthopedic implant market; In 1981, the company's acquisition of SynOptics provided an opportunity to expand into its endoscope business; In 1992, the acquisition of Dimso, SA opened up business opportunities in the field of spinal fixation; In 1996, the acquisition of Osteo SA provided an opportunity to enter the bone trauma market; In 1997, 18 years after the company was listed on the Nasdaq, the company was listed on the New York Stock Exchange; In 1998, the company acquired Howmedica, a major player in the orthopedic market, and doubled its size in the coming year. In 2009, the company acquired Ascent Healthcare Solutions, Inc., a leading market leader in the U.S. medical device reprocessing and remanufacturing market; In 2011, the company acquired Boston Scientific's neurovascular division, greatly expanding the brand's neurotechnology business; In 2013, the company acquired Trauson Holdings Company Limited to expand into high-value market segments in emerging markets. In the same year, the company's acquisition of MAKO Surgical Corp provided an opportunity to further promote the development of robotic arm-assisted surgery in orthopedics.
Stryker (Beijing) Medical Devices Co., Ltd.
As one of the world's cutting-edge medical technology companies, Stryker works sincerely with customers and is committed to improving healthcare. The company provides a range of innovative products and services including plastic surgery, medical and surgical equipment, neurosurgery and spine-related products to help improve the treatment experience of patients and medical institutions. Dr. Homer Stryker, an orthopedic physician in Kalamazoo, Michigan, invented a series of new products after discovering that some medical products cannot meet the needs of patients. There is growing concern and interest in these new medical products, and Dr. Stryker founded The Orthopaedic Frame Company in 1941, specializing in the production of these innovative medical products. In 1942, the company began to build wedge-shaped turnover beds, which allow caregivers to turn over patients with severe back injuries while keeping their spine fixed; In 1946, Stryker founded The Orthopaedic Frame Company; In 1979, the company issued its shares for the first time, bringing more attention to the company; in the same year, Stryker acquired Osteonics Corp. and entered the orthopedic implant market; In 1981, the company's acquisition of SynOptics provided an opportunity to expand into its endoscope business; In 1992, the acquisition of Dimso, SA opened up business opportunities in the field of spinal fixation; In 1996, the acquisition of Osteo SA provided an opportunity to enter the bone trauma market; In 1997, 18 years after the company was listed on the Nasdaq, the company was listed on the New York Stock Exchange; In 1998, the company acquired Howmedica, a major player in the orthopedic market, and doubled its size in the coming year. In 2009, the company acquired Ascent Healthcare Solutions, Inc., a leading market leader in the U.S. medical device reprocessing and remanufacturing market; In 2011, the company acquired Boston Scientific's neurovascular division, greatly expanding the brand's neurotechnology business; In 2013, the company acquired Trauson Holdings Company Limited to expand into high-value market segments in emerging markets. In the same year, the company's acquisition of MAKO Surgical Corp provided an opportunity to further promote the development of robotic arm-assisted surgery in orthopedics.
Tianjin Reecare Surgical Instruments Co., Ltd.
Tianjin Ruiqi Surgery Equipment Co., Ltd. is located in Tianjin Economic and Technological Development Zone. It is a technology-based enterprise that develops, produces and sells professional automatic stapler series products and energy surgical products. Ricky Surgery mainly focuses on the field of minimally invasive surgery. Its product portfolio covers three series: open stapler, laminoscopic stapler and energy products, providing high-quality and safe open surgical instruments for general, external thoracic, obstetrics and gynecological surgery. Laparoscopic surgical instruments. Ricky Surgery has three R&D centers in the United States, Tianjin and Shanghai. It has been committed to delivering advanced technology and cost-effective minimally invasive surgical products to medical institutions around the world, providing doctors and patients with high-quality minimally invasive surgical treatment solutions. Ricky Surgery has a manufacturing center in Tianjin. The manufacturing center has a construction area of about 21,000 square meters, and has advanced facilities such as 100,000 clean rooms, 10,000 clean rooms, EO sterilization stations, etc. It is also equipped with complete quality testing rooms, engineering laboratories, microbiology laboratories and other facilities. The maximum annual production capacity can reach 10 million products. At present, Ricky's products have covered more than 500 hospitals in China; in overseas markets, Ricky's products have been exported to more than 30 countries including the United States, the United Kingdom, South Korea, Germany, Italy, Australia, Brazil, etc. In 2019, Ricky Surgery officially joined Jianshi Medical Technology Group. Jianshi Medical Technology Group is founded by a group of professionals with rich experience in the medical device industry and bringing together global and Chinese local business capabilities. The company's business covers the research and development, production and marketing of high-value medical consumables, and its product portfolio includes surgical products, neurointervention, peripheral intervention, cardiac intervention and tumor intervention. Ricky Surgery will follow Jianshi Medical to uphold the values of firm beliefs, integrity first, innovative business development, openness and inclusiveness, and efficient execution, and practice the mission of "making medical technology universal and protecting health for life".
Tianjin Reecare Surgical Instruments Co., Ltd.
Tianjin Ruiqi Surgery Equipment Co., Ltd. is located in Tianjin Economic and Technological Development Zone. It is a technology-based enterprise that develops, produces and sells professional automatic stapler series products and energy surgical products. Ricky Surgery mainly focuses on the field of minimally invasive surgery. Its product portfolio covers three series: open stapler, laminoscopic stapler and energy products, providing high-quality and safe open surgical instruments for general, external thoracic, obstetrics and gynecological surgery. Laparoscopic surgical instruments. Ricky Surgery has three R&D centers in the United States, Tianjin and Shanghai. It has been committed to delivering advanced technology and cost-effective minimally invasive surgical products to medical institutions around the world, providing doctors and patients with high-quality minimally invasive surgical treatment solutions. Ricky Surgery has a manufacturing center in Tianjin. The manufacturing center has a construction area of about 21,000 square meters, and has advanced facilities such as 100,000 clean rooms, 10,000 clean rooms, EO sterilization stations, etc. It is also equipped with complete quality testing rooms, engineering laboratories, microbiology laboratories and other facilities. The maximum annual production capacity can reach 10 million products. At present, Ricky's products have covered more than 500 hospitals in China; in overseas markets, Ricky's products have been exported to more than 30 countries including the United States, the United Kingdom, South Korea, Germany, Italy, Australia, Brazil, etc. In 2019, Ricky Surgery officially joined Jianshi Medical Technology Group. Jianshi Medical Technology Group is founded by a group of professionals with rich experience in the medical device industry and bringing together global and Chinese local business capabilities. The company's business covers the research and development, production and marketing of high-value medical consumables, and its product portfolio includes surgical products, neurointervention, peripheral intervention, cardiac intervention and tumor intervention. Ricky Surgery will follow Jianshi Medical to uphold the values of firm beliefs, integrity first, innovative business development, openness and inclusiveness, and efficient execution, and practice the mission of "making medical technology universal and protecting health for life".
NINGBO RAYCAREMED MEDICAL INSTRUMENTS CO., LTD
Ningbo Raycaremed Medical Instruments Co.,Ltd is one of the professional supplier for the Medical Instrument products in China. Our Team has more than 10 years experiences in Medical field. We export our products to customers in Europe, Africa, Asia and America. We are factory ,located in Jiangsu province,which near Shanghai port, we produce Syringe, infusion set, Gloves and Face mask.
In order to fulfill and increasing needs of our trusted and loyal customers,apart from our factory ,we have more than 5 strategic partners which produce urine bags, surgical gowns, medical tubes, wound dressing syringes diagnostics & lab products.
We care the success of our customers,we know that the important of quality,so we set up a strong QC team stay in differences production lines to ensure & control quality.
Our Company is approved by CE&ISO certificates for most of products.
In future, Raycaremed Medical will keep high effcient and professional for every customer, and associating company development with human health. We will keep putting love and respect into our every product all the way, and do our best effort to bring health to everyone at the world.
NINGBO RAYCAREMED MEDICAL INSTRUMENTS CO., LTD
Ningbo Raycaremed Medical Instruments Co.,Ltd is one of the professional supplier for the Medical Instrument products in China. Our Team has more than 10 years experiences in Medical field. We export our products to customers in Europe, Africa, Asia and America. We are factory ,located in Jiangsu province,which near Shanghai port, we produce Syringe, infusion set, Gloves and Face mask.
In order to fulfill and increasing needs of our trusted and loyal customers,apart from our factory ,we have more than 5 strategic partners which produce urine bags, surgical gowns, medical tubes, wound dressing syringes diagnostics & lab products.
We care the success of our customers,we know that the important of quality,so we set up a strong QC team stay in differences production lines to ensure & control quality.
Our Company is approved by CE&ISO certificates for most of products.
In future, Raycaremed Medical will keep high effcient and professional for every customer, and associating company development with human health. We will keep putting love and respect into our every product all the way, and do our best effort to bring health to everyone at the world.
Enochon Medical Technology (Suzhou) Co., Ltd.
Enukang Medical Technology (Suzhou) Co., Ltd. was established in 2014 and was jointly founded by many overseas returnees and senior professionals in the domestic medical industry. It is a Jiangsu Province dual-innovation talent enterprise, a Gusu leading talent enterprise and a park leading talent enterprise. The company was selected as a listed nursery project in Suzhou Industrial Park in 2020 and passed the national high-tech enterprise certification in 2021. The company is headquartered in the Suzhou area of China (Jiangsu) Free Trade Pilot Zone. It has a production base and some R&D cooperation projects in Hefei, and a R&D center in California, USA. In the field of high-end medical devices, the company has independent research and development teams and core technologies for ultrasonic energy platforms, electrosurgical energy platforms, ophthalmic devices and minimally invasive surgical robots, and is committed to high-end ultrasonic, energy surgery, ophthalmology and laparoscopic surgical robots and other surgical instrument systems. The research and development, production, sales and service of high-value consumables, and independent innovation of core technologies is used as a key factor in enhancing the company's core competitiveness, attaching great importance to intellectual property protection. Up to now, the company has applied for 220 domestic patents and 50 international patents.
Enochon Medical Technology (Suzhou) Co., Ltd.
Enukang Medical Technology (Suzhou) Co., Ltd. was established in 2014 and was jointly founded by many overseas returnees and senior professionals in the domestic medical industry. It is a Jiangsu Province dual-innovation talent enterprise, a Gusu leading talent enterprise and a park leading talent enterprise. The company was selected as a listed nursery project in Suzhou Industrial Park in 2020 and passed the national high-tech enterprise certification in 2021. The company is headquartered in the Suzhou area of China (Jiangsu) Free Trade Pilot Zone. It has a production base and some R&D cooperation projects in Hefei, and a R&D center in California, USA. In the field of high-end medical devices, the company has independent research and development teams and core technologies for ultrasonic energy platforms, electrosurgical energy platforms, ophthalmic devices and minimally invasive surgical robots, and is committed to high-end ultrasonic, energy surgery, ophthalmology and laparoscopic surgical robots and other surgical instrument systems. The research and development, production, sales and service of high-value consumables, and independent innovation of core technologies is used as a key factor in enhancing the company's core competitiveness, attaching great importance to intellectual property protection. Up to now, the company has applied for 220 domestic patents and 50 international patents.
Medtronic (Shanghai) Management Co., Ltd.
Covidien, one of the world's earliest providers of medical solutions, dates back to G. Mallinckrodt & Company, founded in St. Louis, Missouri, USA in 1867. In 2007, Tyco Medical was renamed Covidien and was independently listed in the United States. "Co" and "Vi" in the brand name come from Latin, meaning common and life. Tyco Healthcare is an important part of Tyco International Group and is a major global manufacturer of medical equipment and disposable medical products. Tyco Medical's main business includes four major business departments: medical devices, imaging, medicines, and medical supplies. As one of the world-class suppliers of the global healthcare industry, its products are sold to more than 130 countries and regions. Tyco Medical’s mission provides medical staff around the world with excellent and innovative medical products, allowing patients to enjoy high-quality medical services. Since entering China in 2000, Tyco Medical has been committed to promoting a full range of advanced technologies to help improve China's medical care level. Through close cooperation with dealers across the country, Tyco is dedicated to training customers to help customers master advanced technology in order to reduce the overall medical costs of patients and provide better medical services.
Medtronic (Shanghai) Management Co., Ltd.
Covidien, one of the world's earliest providers of medical solutions, dates back to G. Mallinckrodt & Company, founded in St. Louis, Missouri, USA in 1867. In 2007, Tyco Medical was renamed Covidien and was independently listed in the United States. "Co" and "Vi" in the brand name come from Latin, meaning common and life. Tyco Healthcare is an important part of Tyco International Group and is a major global manufacturer of medical equipment and disposable medical products. Tyco Medical's main business includes four major business departments: medical devices, imaging, medicines, and medical supplies. As one of the world-class suppliers of the global healthcare industry, its products are sold to more than 130 countries and regions. Tyco Medical’s mission provides medical staff around the world with excellent and innovative medical products, allowing patients to enjoy high-quality medical services. Since entering China in 2000, Tyco Medical has been committed to promoting a full range of advanced technologies to help improve China's medical care level. Through close cooperation with dealers across the country, Tyco is dedicated to training customers to help customers master advanced technology in order to reduce the overall medical costs of patients and provide better medical services.
Beijing Summit Medical Technology Co., Ltd.
Sumai Medical was founded in July 2007. It was formerly the Ultrasonic Medical Instrument Research Center of Tsinghua University, and is engaged in the research and development and promotion of high-energy ultrasonic knife medical equipment. The company has a high-quality elite team, with the main R&D and management personnel from Tsinghua University, with rich industry experience and remarkable performance. With the purpose of "committing to medical progress and focusing on the service of the practitioner", the company has grown into a integrating R&D, production, marketing and sales based on the strong academic atmosphere, strong innovative technology platform and high-quality talent resources of Tsinghua University. High-tech enterprise. The company is committed to medical progress. After more than 20 years of active exploration, the company has developed a number of high-tech achievements with independent intellectual property rights, and has won many rewards and patents, most of which have been transformed into ultrasonic medical instrument products. The company focuses on operator services. In recent years, Sumai relies on its own academic advantages in research and development and jointly established academic centers with many hospitals. Not only did he actively organize doctors from all over the world to learn and use ultrasound energy platforms, but he also cooperated with doctors to improve clinical procedures and improve surgical results many times, and transformed the results into High performance product. At the same time, the company is based on clinical practice. Technical specialists and knife services not only allow doctors to use Sumai ultrasound knife more skillfully and reassurely, but also provides the company with a steady stream of improvement power. Sumai products have always been the bedside assistant for the operator.
Beijing Summit Medical Technology Co., Ltd.
Sumai Medical was founded in July 2007. It was formerly the Ultrasonic Medical Instrument Research Center of Tsinghua University, and is engaged in the research and development and promotion of high-energy ultrasonic knife medical equipment. The company has a high-quality elite team, with the main R&D and management personnel from Tsinghua University, with rich industry experience and remarkable performance. With the purpose of "committing to medical progress and focusing on the service of the practitioner", the company has grown into a integrating R&D, production, marketing and sales based on the strong academic atmosphere, strong innovative technology platform and high-quality talent resources of Tsinghua University. High-tech enterprise. The company is committed to medical progress. After more than 20 years of active exploration, the company has developed a number of high-tech achievements with independent intellectual property rights, and has won many rewards and patents, most of which have been transformed into ultrasonic medical instrument products. The company focuses on operator services. In recent years, Sumai relies on its own academic advantages in research and development and jointly established academic centers with many hospitals. Not only did he actively organize doctors from all over the world to learn and use ultrasound energy platforms, but he also cooperated with doctors to improve clinical procedures and improve surgical results many times, and transformed the results into High performance product. At the same time, the company is based on clinical practice. Technical specialists and knife services not only allow doctors to use Sumai ultrasound knife more skillfully and reassurely, but also provides the company with a steady stream of improvement power. Sumai products have always been the bedside assistant for the operator.
Easense Medical Technology Co., Ltd.
Shanghai Yisi Medical Technology Co., Ltd. is located in Shanghai Zhangjiang National Independent Innovation Demonstration Zone. It was established in November 2011. It is a high-tech company focusing on the research and development and industrialization of high-end medical devices for minimally invasive oncology surgery. It provides complete tumor micro-enterprises to the world. Chuang Surgery Solutions is a national high-tech enterprise, the Ministry of Industry and Information Technology and Shanghai brand cultivation demonstration unit. Yisi Medical adheres to the cultural concept of "effectiveness, learning, innovation and merit", and takes the mission of "being a high-quality minimally invasive surgical product affordable by patients", and is committed to creating a high-end minimally invasive surgical brand belonging to China. The first decade goal set by the company is to build Yisi Medical into "an industry leader in China's minimally invasive surgery field and an industry participant with important influence in the international market." The company's products are used in minimally invasive surgical operations in the fields of digestive system, respiratory system, urinary system, etc., including oncology surgery, weight loss and pneumothorax.
Easense Medical Technology Co., Ltd.
Shanghai Yisi Medical Technology Co., Ltd. is located in Shanghai Zhangjiang National Independent Innovation Demonstration Zone. It was established in November 2011. It is a high-tech company focusing on the research and development and industrialization of high-end medical devices for minimally invasive oncology surgery. It provides complete tumor micro-enterprises to the world. Chuang Surgery Solutions is a national high-tech enterprise, the Ministry of Industry and Information Technology and Shanghai brand cultivation demonstration unit. Yisi Medical adheres to the cultural concept of "effectiveness, learning, innovation and merit", and takes the mission of "being a high-quality minimally invasive surgical product affordable by patients", and is committed to creating a high-end minimally invasive surgical brand belonging to China. The first decade goal set by the company is to build Yisi Medical into "an industry leader in China's minimally invasive surgery field and an industry participant with important influence in the international market." The company's products are used in minimally invasive surgical operations in the fields of digestive system, respiratory system, urinary system, etc., including oncology surgery, weight loss and pneumothorax.
Wuhan Banbiantian Medical Technology Development Co., Ltd.
Wuhan Banbiantian Medical Technology Development Co., Ltd. is located in the "China Optical Valley" known as the "Light of Hope of China". It covers an area of 23.41 mu and has a total construction area of about 13,000 square meters. Wuhan Banbiantian is a national high-tech enterprise integrating research and development, production and sales of medical equipment. The company has gathered expert resources with many medical professors as the core, and supported by research institutes such as universities to establish a cooperation mechanism for industry, academia and research, integrating advanced electronics, computers, remote consultation, medical biological materials, and imaging. Integrate a variety of high-tech technologies, we will strive to create minimally invasive therapeutic products. At present, Ban Biantian has independently developed and produced new medical products such as Ulika RF ultrasonic knife, speed card RF ultrasonic knife, window ablation knife treatment system, self-coagulation knife treatment system, sharp knife treatment system, dual energy knife and other medical products, leading the way Minimally invasive intervention technology trend. Many inventions have independent intellectual property rights, won high market recognition, and have been successfully exported to dozens of countries including Russia, Brazil, Turkey, India, South Korea, etc.
Wuhan Banbiantian Medical Technology Development Co., Ltd.
Wuhan Banbiantian Medical Technology Development Co., Ltd. is located in the "China Optical Valley" known as the "Light of Hope of China". It covers an area of 23.41 mu and has a total construction area of about 13,000 square meters. Wuhan Banbiantian is a national high-tech enterprise integrating research and development, production and sales of medical equipment. The company has gathered expert resources with many medical professors as the core, and supported by research institutes such as universities to establish a cooperation mechanism for industry, academia and research, integrating advanced electronics, computers, remote consultation, medical biological materials, and imaging. Integrate a variety of high-tech technologies, we will strive to create minimally invasive therapeutic products. At present, Ban Biantian has independently developed and produced new medical products such as Ulika RF ultrasonic knife, speed card RF ultrasonic knife, window ablation knife treatment system, self-coagulation knife treatment system, sharp knife treatment system, dual energy knife and other medical products, leading the way Minimally invasive intervention technology trend. Many inventions have independent intellectual property rights, won high market recognition, and have been successfully exported to dozens of countries including Russia, Brazil, Turkey, India, South Korea, etc.
GE Healthcare is an innovator of global cutting-edge medical technology, diagnostic drugs and digital solutions. It is committed to making hospital operations more efficient, clinical diagnosis more effective, treatments more accurate, and patients healthier by providing integrated solutions, services, and data analysis. and happiness. In the more than 100 years of serving patients and medical institutions, GE Medical has continued to promote personalized, interconnected and more empathetic medical care, while simplifying the patient diagnosis and treatment process. GE Medical's medical imaging, ultrasound, life care and diagnostic drug business covers medical care in all aspects from diagnosis, treatment to monitoring. GE Medical was listed on the Nasdaq Stock Exchange in January 2023. The company's business covers more than 160 countries and regions. Since starting to serve Chinese patients in 1897, GE Medical has begun a century-long process of development in China. GE Medical established its China office in Beijing in 1986. In 1991, it jointly built a local factory "GE Hangwei" (Hangwei General Electric Medical Systems Co., Ltd.) with the former Ministry of Aerospace and the Ministry of Health. So far, it has been all over the country. It has more than 30 offices and has built three "creation centers" in Beijing, Wuxi and Shanghai. It has more than 7,000 employees and a local R&D team of about 1,800 people. Since 2011, it has led the research and development and marketed nearly 110 innovative products. In China, GE Medical has improved the accessibility of precision medicine and high-quality medical resources, and helped the construction of "Healthy China 2030". As one of the first multinational companies to start domestic layout, GE Medical has five major production bases (including six factories) in Beijing, Shanghai, Wuxi, Tianjin and Chengdu, and has built a "domestic" full coverage from universal and affordable to high-end. ability. GE Medical produces CT, X-ray machines, vascular machines, surgical machines and other imaging equipment in Beijing; builds a contrast agent production base in Shanghai; produces magnetic resonance imaging systems in Tianjin; produces ultrasound, anesthesia, electrocardiogram monitoring, and ventilators in Wuxi. , patient monitoring and other clinical nursing equipment. GE Medical's fifth production base in China is under construction in Chengdu; the production base of Sinopharm Devices and GE Medical Joint Venture is under construction in Shenzhen.
General Electric Company
GE Healthcare is an innovator of global cutting-edge medical technology, diagnostic drugs and digital solutions. It is committed to making hospital operations more efficient, clinical diagnosis more effective, treatments more accurate, and patients healthier by providing integrated solutions, services, and data analysis. and happiness. In the more than 100 years of serving patients and medical institutions, GE Medical has continued to promote personalized, interconnected and more empathetic medical care, while simplifying the patient diagnosis and treatment process. GE Medical's medical imaging, ultrasound, life care and diagnostic drug business covers medical care in all aspects from diagnosis, treatment to monitoring. GE Medical was listed on the Nasdaq Stock Exchange in January 2023. The company's business covers more than 160 countries and regions. Since starting to serve Chinese patients in 1897, GE Medical has begun a century-long process of development in China. GE Medical established its China office in Beijing in 1986. In 1991, it jointly built a local factory "GE Hangwei" (Hangwei General Electric Medical Systems Co., Ltd.) with the former Ministry of Aerospace and the Ministry of Health. So far, it has been all over the country. It has more than 30 offices and has built three "creation centers" in Beijing, Wuxi and Shanghai. It has more than 7,000 employees and a local R&D team of about 1,800 people. Since 2011, it has led the research and development and marketed nearly 110 innovative products. In China, GE Medical has improved the accessibility of precision medicine and high-quality medical resources, and helped the construction of "Healthy China 2030". As one of the first multinational companies to start domestic layout, GE Medical has five major production bases (including six factories) in Beijing, Shanghai, Wuxi, Tianjin and Chengdu, and has built a "domestic" full coverage from universal and affordable to high-end. ability. GE Medical produces CT, X-ray machines, vascular machines, surgical machines and other imaging equipment in Beijing; builds a contrast agent production base in Shanghai; produces magnetic resonance imaging systems in Tianjin; produces ultrasound, anesthesia, electrocardiogram monitoring, and ventilators in Wuxi. , patient monitoring and other clinical nursing equipment. GE Medical's fifth production base in China is under construction in Chengdu; the production base of Sinopharm Devices and GE Medical Joint Venture is under construction in Shenzhen.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Abbott Trading (Shanghai) Co., Ltd.
In 1888, Abbott Pharmaceutical Factory was founded in Chicago, USA by its founder, Dr. Wallace C. Abbott, to help people in more than 160 countries and regions around the world live a wonderful life. Abbott has been operating in China as early as the 1930s and has been operating since 1988. Abbott is rooted in China and continues to expand its market. In the past 30 years, it has provided Chinese consumers with a variety of nutritional products, medicines and medical products. At present, in addition to establishing a Chinese headquarters in Shanghai, Abbott has also established 16 offices, 4 factories and 2 R&D centers, with more than 6,000 employees. Abbott develops, produces and distributes products covering nutritional products, medicines, medical devices and diagnostic products. Products and services meet the needs of many aspects from disease prevention to diagnosis, treatment to recovery, and are based on local needs to achieve common health goals. Since 2010, Abbott has continued to invest in the Chinese market, developing, producing and distributing products in China, covering nutritional products, medicines, medical devices and diagnostic products, products and services that can meet the needs of disease prevention to diagnosis and treatment to recovery. . In 2014, the advanced nutritional products factory established in Jiaxing with an investment of US$230 million was officially opened. This is a major investment project in China, showing Abbott's strong attempt to improve the health of all Chinese people. Abbott attaches importance to China's local R&D capabilities, not only establishes R&D centers in Shanghai, but also establishes Shanghai Children's Medical Center with partners. Through local clinical trials and operations, Abbott China's R&D capabilities have been greatly improved. In terms of medical innovation, Abbott China has worked together with other R&D centers around the world to jointly respond to global medical problems. Abbott believes in the potential of life and continues to launch high-quality products and services, ranging from newborns to adults, from nutrition and diagnostics to health care and medical treatment. Abbott's passion and care make science an inexhaustible spring for a healthy life, committed to stimulating everyone's potential and pursuing a healthier and better life.
Abbott Trading (Shanghai) Co., Ltd.
In 1888, Abbott Pharmaceutical Factory was founded in Chicago, USA by its founder, Dr. Wallace C. Abbott, to help people in more than 160 countries and regions around the world live a wonderful life. Abbott has been operating in China as early as the 1930s and has been operating since 1988. Abbott is rooted in China and continues to expand its market. In the past 30 years, it has provided Chinese consumers with a variety of nutritional products, medicines and medical products. At present, in addition to establishing a Chinese headquarters in Shanghai, Abbott has also established 16 offices, 4 factories and 2 R&D centers, with more than 6,000 employees. Abbott develops, produces and distributes products covering nutritional products, medicines, medical devices and diagnostic products. Products and services meet the needs of many aspects from disease prevention to diagnosis, treatment to recovery, and are based on local needs to achieve common health goals. Since 2010, Abbott has continued to invest in the Chinese market, developing, producing and distributing products in China, covering nutritional products, medicines, medical devices and diagnostic products, products and services that can meet the needs of disease prevention to diagnosis and treatment to recovery. . In 2014, the advanced nutritional products factory established in Jiaxing with an investment of US$230 million was officially opened. This is a major investment project in China, showing Abbott's strong attempt to improve the health of all Chinese people. Abbott attaches importance to China's local R&D capabilities, not only establishes R&D centers in Shanghai, but also establishes Shanghai Children's Medical Center with partners. Through local clinical trials and operations, Abbott China's R&D capabilities have been greatly improved. In terms of medical innovation, Abbott China has worked together with other R&D centers around the world to jointly respond to global medical problems. Abbott believes in the potential of life and continues to launch high-quality products and services, ranging from newborns to adults, from nutrition and diagnostics to health care and medical treatment. Abbott's passion and care make science an inexhaustible spring for a healthy life, committed to stimulating everyone's potential and pursuing a healthier and better life.
United Imaging Healthcare Co., Ltd.
Shanghai Lianying Medical Technology Co., Ltd. is committed to providing global customers with all independently developed high-performance medical imaging diagnostic and therapeutic equipment, life science instruments, and innovative solutions covering the entire chain of "basic research-clinical research-medical transformation". Through in-depth collaboration with global universities, hospitals, research institutions and industrial partners, we will continue to break through the boundaries of scientific and technological innovation, accelerate the promotion of precise diagnosis and treatment and forward-looking scientific research exploration, and continuously improve the accessibility of global high-end medical equipment and services.
United Imaging Healthcare Co., Ltd.
Shanghai Lianying Medical Technology Co., Ltd. is committed to providing global customers with all independently developed high-performance medical imaging diagnostic and therapeutic equipment, life science instruments, and innovative solutions covering the entire chain of "basic research-clinical research-medical transformation". Through in-depth collaboration with global universities, hospitals, research institutions and industrial partners, we will continue to break through the boundaries of scientific and technological innovation, accelerate the promotion of precise diagnosis and treatment and forward-looking scientific research exploration, and continuously improve the accessibility of global high-end medical equipment and services.
Lepu Medical Technology (Beijing) Co., Ltd.
Lepu (Beijing) Medical Devices Co., Ltd. (hereinafter referred to as "Lepu Medical") was founded in 1999 and is one of the earliest enterprises in my country to engage in the research and development and manufacturing of cardiac interventional medical devices. For more than 20 years, the company has always focused on serving cardiovascular patients and drives high-quality development with innovation. It has now become the leading cardiovascular health industry platform in China. Its main business covers three major medical devices, drugs, medical services and health management. The sector was awarded the "National Research Center for the Engineering and Technology of Heart Disease Instrument and Instrument Engineering and Technology" by the Ministry of Science and Technology. The company's independently developed products such as bioabsorbable stents, cutting balloons, drug balloons, biodegradable occlusion devices, TAVR valves, artificial intelligence electrocardiocardiogram automatic analysis and diagnosis systems have reached the international leading level. In the future, Lepu Medical will continue to uphold the original intention of "serving cardiovascular patients wholeheartedly", and continue to provide full-life cycle services for disease prevention, diagnosis, drug treatment, surgical treatment, postoperative rehabilitation chronic disease management and re-prevention. On the basis of this, we will continue to increase technological innovation and actively deploy strategic emerging industries such as AI and medical care. While we are committed to providing advanced and high-quality products and services to the majority of patients, we will continue to promote industry technological progress and industrial improvement.
Lepu Medical Technology (Beijing) Co., Ltd.
Lepu (Beijing) Medical Devices Co., Ltd. (hereinafter referred to as "Lepu Medical") was founded in 1999 and is one of the earliest enterprises in my country to engage in the research and development and manufacturing of cardiac interventional medical devices. For more than 20 years, the company has always focused on serving cardiovascular patients and drives high-quality development with innovation. It has now become the leading cardiovascular health industry platform in China. Its main business covers three major medical devices, drugs, medical services and health management. The sector was awarded the "National Research Center for the Engineering and Technology of Heart Disease Instrument and Instrument Engineering and Technology" by the Ministry of Science and Technology. The company's independently developed products such as bioabsorbable stents, cutting balloons, drug balloons, biodegradable occlusion devices, TAVR valves, artificial intelligence electrocardiocardiogram automatic analysis and diagnosis systems have reached the international leading level. In the future, Lepu Medical will continue to uphold the original intention of "serving cardiovascular patients wholeheartedly", and continue to provide full-life cycle services for disease prevention, diagnosis, drug treatment, surgical treatment, postoperative rehabilitation chronic disease management and re-prevention. On the basis of this, we will continue to increase technological innovation and actively deploy strategic emerging industries such as AI and medical care. While we are committed to providing advanced and high-quality products and services to the majority of patients, we will continue to promote industry technological progress and industrial improvement.
Siemens Medical is a world-renowned medical technology company. For 130 years, it has led the innovation of medical technology. The company continues to develop innovative products and services, including artificial intelligence-based applications and digital products that play an increasingly important role in the development of the new generation of medical technology, and further consolidates the fields of in vitro diagnosis, image-guided treatment, in vivo diagnosis and new cancer diagnosis and treatment. The basis of At the same time, Siemens Medical provides a wide range of services and solutions to help medical service providers improve their capabilities and provide patients with high-quality and efficient services. In order to achieve the goal of "Siemens Medical 2025 Strategy", by accelerating business expansion, exploring growth markets related to core businesses such as artificial intelligence, future diagnosis and treatment or technical support services, and completing the next phase of the goal in a more targeted way and method. , further consolidate our market leadership position. In China, Siemens Medical is committed to becoming a trusted partner for China's medical and health system and Chinese patients by meeting the most pressing medical needs. The company has launched a new China strategy for the next three years, and will be "customer-centric" in all aspects, targeting the differentiated needs of different customer groups, establishing a more focused and professional team, and providing an overall solution driven by digitalization. , meet the needs of Chinese customers. In 2022, Siemens Medical China officially released the localization strategy of "National Intelligence Innovation", aiming to deeply participate in the construction of a healthy China as a Chinese company. The upgraded strategy is divided into three dimensions: First, the company will gradually promote the localization of the entire product line, further enrich and improve the product lineage, meet the diversified needs of Chinese customers and patients, and help the local industrial chain transform and upgrade. Second, based on the demand of the Chinese market, the company further deepens its innovation and research and development. On the one hand, it accelerates the implementation of global leading technologies in China, benefiting doctors and patients as soon as possible, and on the other hand, it continues to explore local innovation. Third, the company continues to promote the upgrading of local business models, improve the large-scale application of medical equipment in all fields of the disease process, gradually improve the industrial ecology, and explore and practice multi-dimensional medical and industrial collaborative innovation model.
Siemens Healthineers AG
Siemens Medical is a world-renowned medical technology company. For 130 years, it has led the innovation of medical technology. The company continues to develop innovative products and services, including artificial intelligence-based applications and digital products that play an increasingly important role in the development of the new generation of medical technology, and further consolidates the fields of in vitro diagnosis, image-guided treatment, in vivo diagnosis and new cancer diagnosis and treatment. The basis of At the same time, Siemens Medical provides a wide range of services and solutions to help medical service providers improve their capabilities and provide patients with high-quality and efficient services. In order to achieve the goal of "Siemens Medical 2025 Strategy", by accelerating business expansion, exploring growth markets related to core businesses such as artificial intelligence, future diagnosis and treatment or technical support services, and completing the next phase of the goal in a more targeted way and method. , further consolidate our market leadership position. In China, Siemens Medical is committed to becoming a trusted partner for China's medical and health system and Chinese patients by meeting the most pressing medical needs. The company has launched a new China strategy for the next three years, and will be "customer-centric" in all aspects, targeting the differentiated needs of different customer groups, establishing a more focused and professional team, and providing an overall solution driven by digitalization. , meet the needs of Chinese customers. In 2022, Siemens Medical China officially released the localization strategy of "National Intelligence Innovation", aiming to deeply participate in the construction of a healthy China as a Chinese company. The upgraded strategy is divided into three dimensions: First, the company will gradually promote the localization of the entire product line, further enrich and improve the product lineage, meet the diversified needs of Chinese customers and patients, and help the local industrial chain transform and upgrade. Second, based on the demand of the Chinese market, the company further deepens its innovation and research and development. On the one hand, it accelerates the implementation of global leading technologies in China, benefiting doctors and patients as soon as possible, and on the other hand, it continues to explore local innovation. Third, the company continues to promote the upgrading of local business models, improve the large-scale application of medical equipment in all fields of the disease process, gradually improve the industrial ecology, and explore and practice multi-dimensional medical and industrial collaborative innovation model.
Mindray Medical International Limited
Shenzhen Mindray Biomedical Electronics Co., Ltd. is mainly engaged in the research and development, manufacturing, marketing and services of medical devices. It is always oriented towards customer needs and is committed to providing high-quality products and services to medical institutions around the world. The company integrates innovation, closely follows clinical needs, and supports medical institutions to provide high-quality medical services, thereby helping all over the world improve medical conditions and reduce medical costs. After years of development, the company has become a global advanced medical device and solution supplier. The company is headquartered in Shenzhen, China, with 40 overseas subsidiaries in more than 30 countries in North America, Europe, Asia, Africa, Latin America and other regions; it has 17 subsidiaries and more than 40 branches in China, forming a huge number of subsidiaries. a global R&D, marketing and service network. Since its establishment, the company has been deeply engaged in the medical device field, taking the path of equal importance to endogenous and extrinsic development, constantly expanding its product lines and regions, and has experienced the expansion from a single product to multiple product lines, and from the domestic market to the global market. At present, the company's products have covered three major areas: life information and support, in vitro diagnosis and medical imaging. It has a comprehensive product line in the same industry in China, and meets clinical practice with a safe, efficient and easy-to-use "one-stop" overall solution that meets clinical practice need. The company's products and solutions have been applied to more than 190 countries and regions around the world. In the domestic market, the company's products cover nearly 110,000 medical institutions in China and more than 99% of Grade A hospitals, including the nationally renowned Peking Union Medical College Hospital, the General Hospital of the People's Liberation Army of China, and Shanghai Ruijin Hospital. In the international market, as a long-term partner of global advanced medical institutions, such as Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, Cleveland Medical Center, the company has won the United States, the United Kingdom, Germany, France, Italy. , Spain and other national medical institutions widely recognized.
Mindray Medical International Limited
Shenzhen Mindray Biomedical Electronics Co., Ltd. is mainly engaged in the research and development, manufacturing, marketing and services of medical devices. It is always oriented towards customer needs and is committed to providing high-quality products and services to medical institutions around the world. The company integrates innovation, closely follows clinical needs, and supports medical institutions to provide high-quality medical services, thereby helping all over the world improve medical conditions and reduce medical costs. After years of development, the company has become a global advanced medical device and solution supplier. The company is headquartered in Shenzhen, China, with 40 overseas subsidiaries in more than 30 countries in North America, Europe, Asia, Africa, Latin America and other regions; it has 17 subsidiaries and more than 40 branches in China, forming a huge number of subsidiaries. a global R&D, marketing and service network. Since its establishment, the company has been deeply engaged in the medical device field, taking the path of equal importance to endogenous and extrinsic development, constantly expanding its product lines and regions, and has experienced the expansion from a single product to multiple product lines, and from the domestic market to the global market. At present, the company's products have covered three major areas: life information and support, in vitro diagnosis and medical imaging. It has a comprehensive product line in the same industry in China, and meets clinical practice with a safe, efficient and easy-to-use "one-stop" overall solution that meets clinical practice need. The company's products and solutions have been applied to more than 190 countries and regions around the world. In the domestic market, the company's products cover nearly 110,000 medical institutions in China and more than 99% of Grade A hospitals, including the nationally renowned Peking Union Medical College Hospital, the General Hospital of the People's Liberation Army of China, and Shanghai Ruijin Hospital. In the international market, as a long-term partner of global advanced medical institutions, such as Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, Cleveland Medical Center, the company has won the United States, the United Kingdom, Germany, France, Italy. , Spain and other national medical institutions widely recognized.
Johnson & Johnson (China) Investment Co., Ltd.
Johnson & Johnson Medical Technology’s global history can be traced back to the beginning of Johnson & Johnson’s establishment in the United States in 1886. As one of the healthcare companies with wide business worldwide, Johnson & Johnson originated from the production of sterile surgical sutures and auxiliary materials. For more than a century, Johnson & Johnson Medical Technology has always been committed to becoming a world-leading medical technology innovator and bringing far-reaching significance to human health with rich and diverse professional accumulation, mission-significant scientific innovation, and high enthusiasm for human health. Influence, let people all over the world have a healthy and beautiful life. At present, in the fields of surgery, cardiovascular and professional solutions, orthopedics and ophthalmology, Johnson & Johnson Medical Technology continues to innovate and deepen its efforts around the world, striving to solve unmet medical needs, reimagine the future of human health, and allow medical solutions to Smarter, more minimally invasive, more personalized, protect life and light up every beam of hope. In 1994, Johnson & Johnson Medical Technology entered the Chinese market. Currently, Johnson & Johnson Medical Technology has more than 5,000 employees in China, of which 85% are new generation employees. It is headquartered in Shanghai and has offices in Beijing, Guangzhou and other places. On the road of growing together with China's medical and health industry, we will continue to expand and improve our product layout and supply chain production capacity in China. At present, medical technology has become Johnson & Johnson's largest business segment in China. In recent years, Johnson & Johnson Medical Technology has continued to deepen its layout of end-to-end supply chain systems in China, improve local intelligent manufacturing capabilities, introduce global advanced product, technology and quality management experience, and help the industry develop at a high quality and high speed. The integrated supply chain production base located in Suzhou Industrial Park is a large comprehensive industrial park of Johnson & Johnson Medical Technology in China. It integrates the research and development and manufacturing of medical equipment, technological innovation and cooperation, global shared services, regional procurement and supplier management. and other diversified business functions, among which the intelligent manufacturing factory produces a series of innovative products such as surgery and orthopedics, responds to local demand and supplies globally. Johnson & Johnson Medical Technology not only focuses on cultivating and upgrading local intelligent manufacturing capabilities, but also further focuses on local R&D and innovation capabilities. In addition to Suzhou Supply Chain Base, Guangzhou Beixiu Biotechnology Co., Ltd., a wholly-owned subsidiary of Johnson & Johnson, is a biotechnology company specializing in technology development, research and production of pig-derived biological products. Beixiu independently developed the technology to extract fibrinogen and thrombin from mammalian blood, which is the world's first biomedical innovation. On the road to growing together with China's medical and healthcare industry, Johnson & Johnson Medical Technology has deepened the professional education and training of Chinese professional medical staff and is committed to becoming a trustworthy partner of Chinese medical staff. In line with the purpose of "exploring human technology and caring about human health", three Johnson & Johnson Medical Technology Professional Education Academic Centers located in Beijing, Shanghai and Boao Lecheng Medical Pilot Zone and the digital doctor training and education platform "Ling Yimai" provide professional knowledge, Training to adapt to China's medical service environment and innovative medical education forms will be promoted to the professional and systematic development of continuing medical education. In addition, Johnson & Johnson Medical Technology is also actively working with partners from all walks of life to promote innovation cooperation, accelerate the transformation of innovative results, and serve patients. As part of Johnson & Johnson's China Innovation Engine Strategy, Johnson & Johnson cooperates with local companies to leverage digital technologies such as artificial intelligence, surgical robots, and big data to assist doctors in more effective perioperative work and establish localized digital surgical solutions.
Johnson & Johnson (China) Investment Co., Ltd.
Johnson & Johnson Medical Technology’s global history can be traced back to the beginning of Johnson & Johnson’s establishment in the United States in 1886. As one of the healthcare companies with wide business worldwide, Johnson & Johnson originated from the production of sterile surgical sutures and auxiliary materials. For more than a century, Johnson & Johnson Medical Technology has always been committed to becoming a world-leading medical technology innovator and bringing far-reaching significance to human health with rich and diverse professional accumulation, mission-significant scientific innovation, and high enthusiasm for human health. Influence, let people all over the world have a healthy and beautiful life. At present, in the fields of surgery, cardiovascular and professional solutions, orthopedics and ophthalmology, Johnson & Johnson Medical Technology continues to innovate and deepen its efforts around the world, striving to solve unmet medical needs, reimagine the future of human health, and allow medical solutions to Smarter, more minimally invasive, more personalized, protect life and light up every beam of hope. In 1994, Johnson & Johnson Medical Technology entered the Chinese market. Currently, Johnson & Johnson Medical Technology has more than 5,000 employees in China, of which 85% are new generation employees. It is headquartered in Shanghai and has offices in Beijing, Guangzhou and other places. On the road of growing together with China's medical and health industry, we will continue to expand and improve our product layout and supply chain production capacity in China. At present, medical technology has become Johnson & Johnson's largest business segment in China. In recent years, Johnson & Johnson Medical Technology has continued to deepen its layout of end-to-end supply chain systems in China, improve local intelligent manufacturing capabilities, introduce global advanced product, technology and quality management experience, and help the industry develop at a high quality and high speed. The integrated supply chain production base located in Suzhou Industrial Park is a large comprehensive industrial park of Johnson & Johnson Medical Technology in China. It integrates the research and development and manufacturing of medical equipment, technological innovation and cooperation, global shared services, regional procurement and supplier management. and other diversified business functions, among which the intelligent manufacturing factory produces a series of innovative products such as surgery and orthopedics, responds to local demand and supplies globally. Johnson & Johnson Medical Technology not only focuses on cultivating and upgrading local intelligent manufacturing capabilities, but also further focuses on local R&D and innovation capabilities. In addition to Suzhou Supply Chain Base, Guangzhou Beixiu Biotechnology Co., Ltd., a wholly-owned subsidiary of Johnson & Johnson, is a biotechnology company specializing in technology development, research and production of pig-derived biological products. Beixiu independently developed the technology to extract fibrinogen and thrombin from mammalian blood, which is the world's first biomedical innovation. On the road to growing together with China's medical and healthcare industry, Johnson & Johnson Medical Technology has deepened the professional education and training of Chinese professional medical staff and is committed to becoming a trustworthy partner of Chinese medical staff. In line with the purpose of "exploring human technology and caring about human health", three Johnson & Johnson Medical Technology Professional Education Academic Centers located in Beijing, Shanghai and Boao Lecheng Medical Pilot Zone and the digital doctor training and education platform "Ling Yimai" provide professional knowledge, Training to adapt to China's medical service environment and innovative medical education forms will be promoted to the professional and systematic development of continuing medical education. In addition, Johnson & Johnson Medical Technology is also actively working with partners from all walks of life to promote innovation cooperation, accelerate the transformation of innovative results, and serve patients. As part of Johnson & Johnson's China Innovation Engine Strategy, Johnson & Johnson cooperates with local companies to leverage digital technologies such as artificial intelligence, surgical robots, and big data to assist doctors in more effective perioperative work and establish localized digital surgical solutions.
